Table 3. Ocular mucous membrane pemphigoid: disease stage at diagnosis and at follow-up.
| At diagnosis, n (%) | At follow-up, n (%) | |
|---|---|---|
| Eyes | 100 | 80 |
| Mondino staging | ||
| Stage I | 33/94 (35) | 27/76 (36) |
| Stage II | 34/94 (36) | 19/76 (25) |
| Stage III | 16/94 (17) | 16/76 (21) |
| Stage IV | 11/94 (12) | 14/76 (18) |
| Foster staging | ||
| Stage I | 8/100 (8) | 5/78 (6) |
| Stage II | 21/100 (21) | 11/78 (14) |
| Stage III | 59/100 (59) | 52/78 (67) |
| Stage IV | 12/100 (12) | 10/78 (13) |
| Disease progression | ||
| Mondino | ||
| Worsened by at least one stage | 17/66 (26) | |
| No change | 49/66 (74) | |
| Already stage IV | 8 | |
| Could not assess | 6 | |
| Foster | ||
| Worsened by at least one stage | 11/69 (16) | |
| No change | 58/69 (84) | |
| Already stage IV | 9 | |
| Could not assess | 2 | |
Mondino and Brown: (I) 0–25%, (II) 25–50%, (III) 50–75%, (IV) 75–100% loss of inferior fornix. Foster: (I) subconjunctival scarring and fibrosis, (II) fornix foreshortening of any degree, (III) presence of any degree of symblepharon, (IV) end-stage cicatricial pemphigoid.